Long-term Aseptic Revision & Advanced Hip Arthroplasty Database
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
Total hip arthroplasty (THA) volumes continue to rise each year as the population ages and indications broaden. Increasingly, younger patients require hip replacement for conditions beyond primary osteoarthritis or fractures. As a result, the number of revision procedures is growing and is expected to increase further.
Prospective data collection within this population will enable us to address key uncertainties, particularly around optimal implant selection for complex primary and revision cases.
In addition, establishing a structured prospective database will allow for systematic internal auditing for quality assurance. Even simple metrics - such as verifying whether every patient received a complete diagnostic infection workup before revision surgery - could immediately enhance service quality and inform improvements to clinical pathways.
Eligibility criteria
Qualifiers
THA with hardware removal
THA for hip dysplasia
THA with femoral deformity or prior corrective surgery
THA after LCPD, SCFE or septic arthritis
Disqualifiers
Patients unable to provide written informed consent
Patients who prefer treatment outside of University Hospitals Leuven
Patients with proven PJI according to the 2021 EBJIS criteria
Patients undergoing standard, non-complex, hip replacement as judged by the treating physician.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov